Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | EI1 |
Synonyms | |
Therapy Description |
EI1 is a selective inhibitor of EZH2, which results in reduced H3K27 methylation and reduced expression of EZH2 target genes, and may lead to decreased tumor cell growth (PMID: 23236167). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
EI1 | KB-145943 | EZH2 inhibitor 20 | EI1 is a selective inhibitor of EZH2, which results in reduced H3K27 methylation and reduced expression of EZH2 target genes, and may lead to decreased tumor cell growth (PMID: 23236167). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|